T H E N I H C A T A L Y S T | M A R C H A P R I L 2000 |
|
CALL FOR CATALYTIC REACTIONS | ||||
In this issue, we are asking for your reactions in four areas: clinical research standards for the IRP, gene therapy oversight, "plain language" plans, and your own research. Send your responses on these topics or your comments on other intramural
research concerns to us via e-mail:
|
1.What's your opinion of the new standards for carrying out clinical research at NIH?
2.Do you think there's a need for additional federal oversight of human gene therapy experiments? Should the NIH Recombinant DNA Advisory Committee (RAC) once again have protocol-approving authority, along with the Food and Drug Administration, for gene therapy trials?
4.Is there some fascinating research going on in your laboratory you'd like the wider NIH community to know about?
|
|||
The NIH Catalyst is published bi-monthly for and by the intramural scientists at NIH. Address correspondence to Building 1, Room 209, NIH, Bethesda, MD 20892. Ph: (301) 402-1449; fax: (301) 402-4303; e-mail: <catalyst@nih.gov>. |
|